Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naldebain® Extended-release Injection After Cesarean Section in Pain Management: a Prospective Observational Study

NCT05446311 is registered in ClinicalTrials.gov with Tri-Service General Hospital (TSGH) as lead sponsor.

NCT NCT05446311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naldebain® Extended-release Injection After Cesarean Section in Pain Management: a Prospective Observational Study
Lead sponsor
Tri-Service General Hospital (TSGH)
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2022
Completion date
December 31, 2022
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, caesarean section, post operative pain